FDA.reportPublic FDA data

Garnier Skin Renew Miracle Skin Perfector

Manufacturer
L'Oreal USA Products Inc
Effective date
2022-01-13
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 22:17:04

Label at a glance#

ProductGarnier Skin Renew Miracle Skin Perfector
Active ingredientOctinoxate
Label structure8 sections

Dosage and administration

Gently apply Garnier Skin Renew Miracle Skin Perfector to face and neck prior to sun exposure for instant coverage and correction as well as for protection. Reapply as needed.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Octinoxate 4%

Directions

DOSAGE & ADMINISTRATION SECTION

Gently apply Garnier Skin Renew Miracle Skin Perfector to face and neck prior to sun exposure for instant coverage and correction as well as for protection. Reapply as needed.

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

Avoid contact with eyes. 

Stop use

OTC - STOP USE SECTION

if signs of irritation or rash appear. 

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, isononyl isononanoate, isohexadecane, glycerin, alcohol denat., PEG-20 methyl glucose sesquistearate, methyl glucose sesquistearate, cetyl palmitate, nylon-12, cyclohexasiloxane, propylene glycol, hydrogenated polyisobutene, stearyl alcohol, magnesium aluminum silicate, phenoxyethanol, fragrance, caprylyl glycol, lithium magnesiuim sodium silicate, disodium EDTA, linalool, benzyl salicylate, limonene, caffeine, ascorbyl glucoside, benzyl alcohol, geraniol, cellulose acetate butyrate, polyphosphorylcholine glycol acrylate, citral, ammonium polyacryloyldimethyl taurate, polyvinyl alcohol, sodium chloride, butylene glycol, sodium hyaluronate; may contain: titanium dioxide, iron oxides

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

imageof a labelimageof a label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OctinoxateACTIVE INGREDIENT4Y5P7MUD511
OctinoxateACTIVE MOIETY4Y5P7MUD511

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49967-17149967-171-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
NameUNIIKind
Octinoxate4Y5P7MUD51ACTIB
WATER059QF0KO0RIACT
ISONONYL ISONONANOATES4V5BS6GCXIACT
ISOHEXADECANE918X1OUF1EIACT
GLYCERINPDC6A3C0OXIACT
ALCOHOL3K9958V90MIACT
PEG-20 METHYL GLUCOSE SESQUISTEARATE0345752X7UIACT
METHYL GLUCOSE SESQUISTEARATEV1YW10H14DIACT
CETYL PALMITATE5ZA2S6B08XIACT
NYLON-12446U8J075BIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
STEARYL ALCOHOL2KR89I4H1YIACT
MAGNESIUM ALUMINUM SILICATE6M3P64V0NCIACT
PHENOXYETHANOLHIE492ZZ3TIACT
CAPRYLYL GLYCOL00YIU5438UIACT
BENZYL SALICYLATEWAO5MNK9TUIACT
CAFFEINE3G6A5W338EIACT
ASCORBYL GLUCOSIDE2V52R0NHXWIACT
BENZYL ALCOHOLLKG8494WBHIACT
GERANIOLL837108USYIACT
SODIUM CHLORIDE451W47IQ8XIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
TITANIUM DIOXIDE15FIX9V2JPIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
468b4178-8a55-4543-a132-1ca1cedcfdaa4eeb4521-8594-41e9-86e9-abe4f0d1e4e82024-01-01WarningsExact identifier
spl set id: 4eeb4521-8594-41e9-86e9-abe4f0d1e4e8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.